Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Blood Processing Devices and Consumables Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12107| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Blood Processing Devices and Consumables Market size stood at USD 58.43 billion in 2026 and is predicted to grow at a 6.75% CAGR from 2027 to 2036, reaching USD 112.28 billion by 2036. The industry revenue for 2027 is calculated at USD 61.75 billion.

Base Year Value (2026)
USD 58.43 billion
CAGR (2027-2036)
6.75%
Forecast Year Value (2036)
USD 112.28 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Blood Processing Devices and Consumables Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 41.87% market share in 2026, supported by established transfusion infrastructure, broad hospital and blood bank networks, standardized workflows, and consistent consumable replacement demand.
  • Asia Pacific is expected to expand at an 8.14% CAGR as healthcare capacity grows, blood donation and transfusion activity increases, and hospitals and blood banks adopt modern processing equipment.

Segment Momentum

  • Devices accounted for 58.98% of the market in 2026 due to their essential role in blood collection, separation, and processing workflows, supported by a broad installed base across healthcare and laboratory facilities.
  • Diagnostic laboratories are growing the fastest because their high-throughput infrastructure supports efficient, standardized blood processing, making them well positioned to meet rising testing and processing volumes.

Market Expansion Drivers

  • Rising prevalence of infectious and transfusion-dependent diseases increasing blood processing demand.
  • Growing surgical procedures and organ transplants driving blood storage and transfusion requirements.
  • Advancements in blood screening and processing technologies improving patient safety and operational accuracy.

Leading Market Participants

  • Key players in the blood processing devices and consumables market include Terumo Corporation (Japan), Haemonetics Corporation (United States), Grifols, S.A. (Spain), Becton, Dickinson and Company (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (United States), Danaher Corporation (United States), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (United States), Macopharma SA (France).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 58.43 billion
  • 2027 Estimated Market Size: USD 61.75 billion.
  • Projected Market Size: USD 112.28 billion by 2036
  • Growth Forecast: 6.75% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Devices (Product) | Hospitals and Clinics (End-use)
  • Emerging Opportunity Segment: Consumables (Product) | Diagnostic Laboratories (End-use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of infectious and transfusion-dependent diseases increasing blood processing demand

The increasing incidence of infectious and transfusion-dependent diseases will drive the blood processing devices and consumables market by raising the need for reliable blood collection, separation, testing, storage, and transfusion workflows. Conditions requiring repeated transfusions place sustained pressure on healthcare facilities and blood banks to maintain adequate supplies of safely processed blood components. At the same time, infectious diseases can increase the need for comprehensive blood screening and component-level processing to minimize transmission risks during transfusion. Healthcare providers therefore require dependable centrifugation systems, blood collection products, filtration equipment, storage solutions, and related consumables to manage growing processing volumes while maintaining quality and compatibility standards.

Growing surgical procedures and organ transplants driving blood storage and transfusion requirements

Expanding surgical activity and the increasing complexity of organ transplantation procedures will propel the blood processing devices and consumables market as hospitals require dependable access to appropriately processed blood components before, during, and after major interventions. Complex surgeries and transplantation procedures can involve substantial blood management requirements, making efficient collection, component separation, preservation, and controlled storage essential for clinical operations. Blood banks and hospital transfusion departments consequently need equipment and consumables that support the preparation and availability of red blood cells, plasma, platelets, and other components under controlled conditions. Greater emphasis on perioperative blood management also encourages healthcare facilities to strengthen processing capacity and maintain consistent transfusion readiness.

Advancements in blood screening and processing technologies improving patient safety and operational accuracy

Technological progress in screening, separation, filtration, and automated blood handling is boosting the blood processing devices and consumables market by enabling healthcare facilities to improve the accuracy and consistency of blood component preparation. Modern processing technologies can support more controlled workflows, reduce manual intervention, and facilitate the identification of potentially unsuitable blood products before transfusion. Automation and improved analytical capabilities also help laboratories and blood centers manage processing activities with greater operational precision while supporting stringent quality requirements. As healthcare systems place greater emphasis on transfusion safety and standardized blood management practices, demand is increasing for sophisticated processing equipment, screening systems, and specialized consumables.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of infectious and transfusion-dependent diseases increasing blood processing demand 2.10% High North America, Asia Pacific High Near Term
Growing surgical procedures and organ transplants driving blood storage and transfusion requirements 1.90% High North America, Europe, Asia Pacific High Mid Term
Advancements in blood screening and processing technologies improving patient safety and operational accuracy 1.60% High Europe, North America Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Blood Processing Devices and Consumables Market
Largest Region
North America
41.87% Market Share in 2026

North America (Largest Region)

North America held a 41.87% share of the blood processing devices and consumables market in 2026, supported by sophisticated healthcare infrastructure, established blood banking systems, and strong adoption of advanced technologies for blood collection, separation, storage, and testing. The region's emphasis on transfusion safety, quality control, and efficient blood management encourages healthcare institutions to invest in reliable processing equipment and consumables. Ongoing modernization of clinical and laboratory facilities, together with demand for improved blood component management, continues to reinforce regional adoption.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is experiencing rapid expansion as healthcare infrastructure develops and access to blood-related medical services improves across the region. Growing demand for transfusion services, increasing investment in hospitals and diagnostic facilities, and efforts to strengthen blood collection and storage systems are supporting broader use of processing devices and consumables. Greater attention to transfusion safety and modernization of healthcare delivery is also encouraging the adoption of more efficient blood processing technologies.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Quality-Focused Processing Systems

Germany emphasizes precision blood processing supported by high-quality laboratory equipment and standardized clinical workflows. Healthcare institutions in Germany are adopting advanced consumables and automated systems to improve processing efficiency while maintaining strict quality requirements.

France 🇫🇷

Transfusion Service Enhancement

France focuses on strengthening blood processing capabilities through reliable equipment and standardized consumable usage. Healthcare providers in France are improving component preparation and laboratory operations by adopting technologies that enhance efficiency, traceability, and product quality.

Italy 🇮🇹

Laboratory Efficiency Solutions

Italy is increasing adoption of blood processing devices and consumables that streamline laboratory operations and support reliable blood component preparation. Healthcare facilities in Italy are modernizing processing workflows through automation and standardized consumables that improve operational consistency and clinical readiness.

Japan 🇯🇵

Automated Laboratory Workflows

Japan prioritizes highly automated blood processing solutions that enhance laboratory productivity and procedural consistency. Medical facilities in Japan are integrating advanced processing devices and specialized consumables to support efficient blood component preparation and reliable clinical operations.

South Korea 🇰🇷

Modern Clinical Processing

South Korea is expanding the use of advanced blood processing technologies across hospitals and diagnostic laboratories. Healthcare organizations in South Korea are investing in automated equipment and high-performance consumables that improve workflow efficiency and support consistent blood handling practices.

United States 🇺🇸

Advanced Blood Processing

The U.S. blood processing devices and consumables market benefits from continuous investment in automation, component separation, and transfusion safety. Healthcare providers in the U.S. are expanding advanced processing technologies that improve laboratory efficiency, consistency, and blood product quality.

Segment Analysis

Segment Leadership and Growth Trends

Blood Processing Devices and Consumables Market Share (%), by Product, 2026

Devices
Consumables

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Devices (Largest Segment) vs Consumables (Fastest-Growing Segment)

The devices segment held the largest share of the blood processing devices and consumables market, accounting for 58.98% in 2026. Blood processing devices form the core of collection, separation, preparation, and other processing activities, supporting consistent and efficient handling of blood and its components. Demand is reinforced by the need for reliable equipment across healthcare and laboratory settings, where precision, workflow efficiency, and standardized processing are essential. Ongoing improvements in automation and processing capabilities further support the strong position of the devices segment.

The consumables segment is expected to be the fastest-growing product segment, driven by their recurring use throughout blood processing procedures. Items required for routine collection, preparation, testing, and handling must be replenished regularly, creating sustained demand as blood processing activities expand. Increasing emphasis on safe, hygienic, and efficient workflows, along with the continued need for compatible single-use and procedure-specific materials, is expected to strengthen growth across this segment.

End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Diagnostic Laboratories (Fastest-Growing Segment)

In the blood processing devices and consumables market, hospitals and clinics held the largest end-use share in 2026. These healthcare facilities conduct a wide range of activities requiring blood collection, processing, and preparation, supported by their established clinical infrastructure and broad patient volumes. The integration of blood-related procedures into routine diagnostics, treatment support, and specialized care contributes to sustained demand for both processing equipment and associated supplies. The need for efficient in-house workflows and timely availability of processed blood components further reinforces the segment's leading position.

Diagnostic laboratories are expected to be the fastest-growing end-use segment as demand increases for efficient and standardized processing to support expanding diagnostic workloads. Laboratories require dependable systems and consumables that can support accuracy, consistency, and streamlined handling across high-throughput testing environments. Greater adoption of automated laboratory processes and the increasing focus on timely diagnostic services are likely to support faster growth in this segment.

Segment Sub-Segment Largest Segment Fastest Growing
Product Devices, Consumables Devices Consumables
End-use Hospitals and Clinics, Diagnostic Laboratories, Others Hospitals and Clinics Diagnostic Laboratories
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the blood processing devices and consumables market:

1. Terumo Corporation (Japan)

2. Haemonetics Corporation (United States)

3. Grifols S.A. (Spain)

4. Becton Dickinson and Company (United States)

5. F. Hoffmann-La Roche Ltd. (Switzerland)

6. Abbott Laboratories (United States)

7. Danaher Corporation (United States)

8. bioMérieux SA (France)

9. Bio-Rad Laboratories Inc. (United States)

10. Macopharma SA (France)

The blood processing devices and consumables market is advancing through innovation in automated processing systems and safer blood handling technologies. Manufacturers are focusing on improving separation efficiency, sterility, and operational precision in clinical environments. Expanding adoption of advanced medical technologies is driving continuous enhancements in transfusion and laboratory workflows.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Terumo Corporation (Japan)
Haemonetics Corporation (United States)
Grifols S.A. (Spain)
Becton Dickinson and Company (United States)
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott Laboratories (United States)
Danaher Corporation (United States)
bioMérieux SA (France)
Bio-Rad Laboratories Inc. (United States)
Macopharma SA (France).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Blood Processing Devices and Consumables Market — Custom Segments

Segment Sub-Segment
Processing Procedure Blood Separation, Blood Component Processing, Blood Filtration, Blood Cell Processing
Blood Collection Type Whole Blood Collection, Apheresis Collection, Cord Blood Collection
Purchasing Channel Direct Procurement, Group Purchasing Organizations, Distributors & Wholesalers

Blood Processing Devices and Consumables Market — Custom TOC

Custom Chapter Custom Details
Blood Center Procurement and Capital Investment Outlook
  • Blood Center Equipment Replacement and Capacity Investment Priorities
  • Procurement Models and Capital Allocation Drivers
  • Equipment Specification and Vendor Selection Criteria
  • Facility Modernization and Processing Capacity Requirements
  • Investment Priorities Across Blood Processing Operations
Plasma Fractionation Capacity and Collection Infrastructure Benchmarking
  • Plasma Collection Infrastructure and Capacity Development
  • Fractionation Facility Footprint and Processing Requirements
  • Collection-to-Fractionation Network Efficiency
  • Capacity Expansion and Infrastructure Investment Priorities
  • Regional Infrastructure Gaps and Opportunity Areas
Emerging Cell and Gene Therapy Processing Opportunity Assessment
  • Blood Processing Requirements Across Cell and Gene Therapy Workflows
  • Collection, Separation and Processing Technology Applications
  • Facility and Workflow Integration Requirements
  • Adoption Drivers Across Therapy Development and Manufacturing
  • Emerging Opportunity Areas for Processing Technologies

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the blood processing devices and consumables market?

The market valuation of the blood processing devices and consumables is USD 61.75 billion in 2027.

What is the projected value of the blood processing devices and consumables industry by 2036?

Blood Processing Devices and Consumables Market size stood at USD 58.43 billion in 2026 and is predicted to grow at a 6.75% CAGR from 2027 to 2036, reaching USD 112.28 billion by 2036.

How are advances in blood screening technologies influencing purchasing decisions in the blood processing devices and consumables market?

Healthcare providers are prioritizing automated, high-accuracy processing platforms that improve traceability, reduce manual handling, enhance component consistency, and support standardized workflows while driving recurring demand for compatible consumables.

What operational trends are increasing demand for blood processing devices and consumables?

Higher blood processing volumes driven by infectious diseases, transfusion-dependent conditions, surgeries, and organ transplants are encouraging investments in reliable processing equipment, expanded storage capacity, and consumables that improve quality control and turnaround efficiency.

Why do devices lead the blood processing devices and consumables market?

Devices accounted for 58.98% of the market in 2026 due to their essential role in blood collection, separation, and processing workflows, supported by a broad installed base across healthcare and laboratory facilities.

Why are diagnostic laboratories the fastest-growing end-use segment in the blood processing devices and consumables market?

Diagnostic laboratories are growing the fastest because their high-throughput infrastructure supports efficient, standardized blood processing, making them well positioned to meet rising testing and processing volumes.

Why is North America the leading market for blood processing devices and consumables?

North America held a 41.87% market share in 2026, supported by established transfusion infrastructure, broad hospital and blood bank networks, standardized workflows, and consistent consumable replacement demand.

What factors are accelerating growth in the blood processing devices and consumables market in Asia Pacific?

Asia Pacific is expected to expand at an 8.14% CAGR as healthcare capacity grows, blood donation and transfusion activity increases, and hospitals and blood banks adopt modern processing equipment.

Who are the leading players in the blood processing devices and consumables landscape?

Key players in the blood processing devices and consumables market include Terumo Corporation (Japan), Haemonetics Corporation (United States), Grifols, S.A. (Spain), Becton, Dickinson and Company (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (United States), Danaher Corporation (United States), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (United States), Macopharma SA (France).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →